Management of recurrent vulvovaginal candidiasis: Unresolved issues
Author:
- 1 November 2006
- journal article
- research article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 8 (6) , 481-486
Abstract
The introduction and widespread use of long-term maintenance suppressive fluconazole prophylaxis for recurrent vulvovaginal candidiasis (RVVC) has improved the quality of life for thousands of women worldwide. Moreover, the regimen is no longer expensive, and it is safe and well tolerated. However, the regimen frequently fails to cure the condition and serves only as an effective control measure in many cases. Moreover, some women are unable to tolerate the regimen, and new curative approaches are needed. This review presents the limitations of this suppressive regimen and a discussion of the possible reasons for these limitations and failure to cure. Also, the rationale for new drug development is reviewed here.Keywords
This publication has 24 references indexed in Scilit:
- Frequency of Interleukin-4 (IL-4) -589 Gene Polymorphism and Vaginal Concentrations of IL-4, Nitric Oxide, and Mannose-Binding Lectin in Women with Recurrent Vulvovaginal CandidiasisClinical Infectious Diseases, 2005
- Maintenance Fluconazole Therapy for Recurrent Vulvovaginal CandidiasisNew England Journal of Medicine, 2004
- History and new insights into host defense against vaginal candidiasisTrends in Microbiology, 2004
- Fungicidal Activity of Fluconazole against Candida albicans in a Synthetic Vagina-Simulative MediumAntimicrobial Agents and Chemotherapy, 2004
- Vaginitis Due toCandida krusei:Epidemiology, Clinical Aspects, and TherapyClinical Infectious Diseases, 2002
- Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole ProphylaxisClinical Infectious Diseases, 2001
- Prevalence of Vaginal Colonization by Drug‐ResistantCandidaSpecies in College‐Age Women with Previous Exposure to Over‐the‐Counter Azole AntifungalsClinical Infectious Diseases, 2001
- Symptomatic Vulvovaginitis Due to Fluconazole-Resistant Candida albicans in a Female Who Was Not Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1996
- Recurrent Vulvovaginal CandidiasisNew England Journal of Medicine, 1986
- Recurrent genital candidosis in women and the effect of intermittent prophylactic treatmentSexually Transmitted Infections, 1978